4Gene is advancing TUM research into exploiting plant-derived glucosides as flexible triggers for releasing flavouring and aromas.

The banking software development platform received series A funding from investors including HSBC and Goldman Sachs, which co-led the round, Banco Sabadell and ANZ.

Orange and Experian have both taken part in a round that will be used to expand the reach of Aire's credit assessment tool in the US.

VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.

Altice has reportedly acquired a 60% share of the live TV streaming service, while existing shareholders such as Sky will retain a stake in the business.

US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Cambridge-founded automated cell analytics platform Sphere Fluidics has added $2m of funding, bringing its lifetime haul to $14.9m.

Deutsche Kreditbank and LGT Group have put their weight behind Loanboox’s $22.2m series B round, which has boosted the lending marketplace’s valuation to $122m.

Members of SetSquared Bristol generated less funding than in 2017, though it may instead remember last year for diabetes treatment developer Ziylo's sale to Novo for up to $800m.